The project ‘The development of innovative solutions ensuring the increase of effectiveness and efficiency of key manufacturing processes of OTC drugs and contributing to the increase of their microbiological safety’ is co-financed by the European Regional Development Fund under the Operational Programme Intelligent Development 2014-2020, Measure 1.1: “R&D projects of enterprises”, Sub-measure 1.1.1: “Industrial research and development works carried out by enterprises. The project is implemented under the competition held by the National Centre for Research and Development: Competition No. 6/1.1.1/2020 “Fast Track”.
The aim of the project is to develop a process innovation in the form of highly effective and highly efficient technological solutions dedicated to the manufacturing process of over-the-counter drugs (OTC) manufactured at US Pharmacia.
The result will be an improvement in the area of automation and optimization of key stages of the OTC drug manufacturing process.
The implementation of the project results will be carried out by introducing them into our Company’s own business activity.
The project is being implemented in the period from 24/12/2020 to 31/10/2023.
The received subsidy is PLN 8,163,787.74.
The value of the entire project is estimated at PLN 19,929,015.39.
USP Zdrowie
Back to projects list